Similar to Fingolimod treatment, S1P1 antagonism by EX26 reverses the pathology of experimental autoimmune encephalomyelitis (EAE) which depends on significant lymphocyte sequestration in the lymph nodes [32]. The gene discussed is S1PR1; the disease is experimental autoimmune encephalomyelitis.